EE201100029A - Stabiilse koostisega ravimkoostis, mis sisaldab amlodipiini ja bisoprolooli ning meetod selle valmistamiseks - Google Patents

Stabiilse koostisega ravimkoostis, mis sisaldab amlodipiini ja bisoprolooli ning meetod selle valmistamiseks

Info

Publication number: EE201100029A
Authority: EE; Estonia
Prior art keywords: bisoprolol; amlodipine; preparation; pharmaceutical composition; stable pharmaceutical
Prior art date: 2008-09-30

Application number

EEP201100029A

Other languages

English (en)

Inventor

βszl� Wagner L

Zsigmond Zsolt

Ujfalussy Gy�rgy

Leventiszn� Husz βr Magdolna

Tonka-Nagy P�ter

B βrczay Erzs�bet

βszl�n� G�ra L

Szeleczki Edit

F�l�p Agnes

Original Assignee

EGIS Gy�gyszergy βr Nyilv βnosan M�k�d� R�szv�nyt βrsas βg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-09-30

Filing date

2009-09-30

Publication date

2011-06-15

2009-09-30 Application filed by EGIS Gy�gyszergy βr Nyilv βnosan M�k�d� R�szv�nyt βrsas βg filed Critical EGIS Gy�gyszergy βr Nyilv βnosan M�k�d� R�szv�nyt βrsas βg

2011-06-15 Publication of EE201100029A publication Critical patent/EE201100029A/et

2014-10-15 Publication of EE05723B1 publication Critical patent/EE05723B1/et

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Peptides Or Proteins (AREA)
Packages (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Hydrogenated Pyridines (AREA)

EEP201100029A 2008-09-30 2009-09-30 Stabiilse koostisega ravimkoostis, mis sisaldab amlodipiini ja bisoprolooli, ning meetod selle valmistamiseks EE05723B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HUP0800591A HU230877B1 (hu)	2008-09-30	2008-09-30	Stabil kombinációs gyógyszerkészítmény
PCT/HU2009/000085 WO2010038091A2 (en)	2008-09-30	2009-09-30	Stable combination pharmaceutical composition

Publications (2)

Publication Number	Publication Date
EE201100029A true EE201100029A (et)	2011-06-15
EE05723B1 EE05723B1 (et)	2014-10-15

Family

ID=89988527

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP201100029A EE05723B1 (et)	2008-09-30	2009-09-30	Stabiilse koostisega ravimkoostis, mis sisaldab amlodipiini ja bisoprolooli, ning meetod selle valmistamiseks

Country Status (31)

Country	Link
EP (2)	EP2344141B1 (et)
KR (1)	KR101772619B1 (et)
CN (1)	CN102164585B (et)
AT (2)	AT510866A3 (et)
BG (1)	BG66274B1 (et)
CH (1)	CH702345B1 (et)
CY (1)	CY1122084T1 (et)
CZ (2)	CZ308237B6 (et)
DE (1)	DE202009019152U1 (et)
DK (1)	DK2344141T3 (et)
EA (2)	EA026238B9 (et)
EE (1)	EE05723B1 (et)
ES (2)	ES2385988B2 (et)
GE (1)	GEP20135859B (et)
HR (3)	HRP20191373T1 (et)
HU (3)	HU230877B1 (et)
LT (3)	LT2344141T (et)
ME (1)	ME03774B (et)
MX (2)	MX2011003407A (et)
MY (1)	MY175270A (et)
PL (3)	PL2344141T3 (et)
PT (3)	PT2344141T (et)
RO (1)	RO127490B1 (et)
RS (3)	RS59201B1 (et)
RU (2)	RU2687282C2 (et)
SG (1)	SG194392A1 (et)
SI (2)	SI2344141T1 (et)
SK (2)	SK7997Y1 (et)
SM (1)	SMT201900434T1 (et)
UA (1)	UA101407C2 (et)
WO (1)	WO2010038091A2 (et)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU230877B1 (hu)	2008-09-30	2018-11-29	EGIS Gyógyszergyár NyR	Stabil kombinációs gyógyszerkészítmény
CN101766611B (zh) *	2010-02-09	2011-10-12	施慧达药业集团(吉林)有限公司	一种左旋氨氯地平或其可药用盐和β受体阻滞剂的药物组合物及其应用
EP3501501A1 (en)	2012-02-17	2019-06-26	Egis Gyógyszergyár Zrt.	Pharmaceutical formulation having improved stability
HUE066123T2 (hu) *	2013-06-13	2024-07-28	Akebia Therapeutics Inc	Készítmények és módszerek anémia kezelésére
HUP1300496A2 (hu)	2013-08-16	2015-03-02	Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag	Stabil kombinációs gyógyszerkészítmény
FR3027803B1 (fr)	2014-11-05	2018-02-09	Les Laboratoires Servier	Composition pharmaceutique comprenant un betabloquant et un inhibiteur de l'enzyme de conversion
PH12018502155B1 (en)	2016-04-20	2024-03-27	Servier Lab	Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid
EP4583847A1 (en)	2022-09-07	2025-07-16	Kinast, Lasse	An immediate-release oral pharmaceutical form of amlodipine with increased api content
CN116687926B (zh) *	2023-07-27	2023-12-12	石家庄四药有限公司	一种比索洛尔氨氯地平复方片剂及其制备方法
EP4710920A1 (en)	2024-09-16	2026-03-18	Adamed Pharma S.A.	Pharmaceutical composition comprising combination of amlodipine, ramipril and rosuvastatin

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU221810B1 (hu) *	1997-08-12	2003-01-28	EGIS Gyógyszergyár Rt.	Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
GB0001621D0 (en) *	2000-01-26	2000-03-15	Astrazeneca Ab	Pharmaceutical compositions
CA2433181C (en)	2000-12-29	2005-11-22	Pfizer Limited	Amlodipine hemifumarate
AT5874U1 (de) *	2000-12-29	2003-01-27	Bioorg Bv	Pharmazeutische zubereitungen enthaltend amlodipinmaleat
AU2001100431A4 (en) *	2001-10-03	2001-11-01	Pfizer Limited	Pharmaceutical compositions comprising amlodipine maleate
WO2003032954A1 (en)	2001-10-17	2003-04-24	Dr. Reddy's Laboratories Ltd.	Stabilized pharmaceutical formulations containing amlodipine maleate
WO2004075825A2 (en) *	2003-02-28	2004-09-10	Ranbaxy Laboratories Limited	Dosage forms of amlodipine and processes for their preparation
WO2005051350A2 (en) *	2003-10-28	2005-06-09	Torrent Pharmaceuticals Limited	Water dispersible tablet
WO2005099699A1 (en) *	2004-04-07	2005-10-27	Sepracor Inc.	Combination of (s)-amlodipine and a beta-blocker, and methods for reducing hypertension
IN224215B (et) *	2004-08-05	2009-02-06
WO2006059217A1 (en) *	2004-12-01	2006-06-08	Ranbaxy Laboratories Limited	Stable solid dosage forms of amlodipine besylate and processes for their preparation
CZ2005141A3 (cs) *	2005-03-07	2006-04-12	Lunaria, Spol. S. R. O.	Lécivý prípravek na bázi amlodipin-besilátu se zvýsenou stabilitou
IES20070122A2 (en) *	2006-12-05	2008-05-28	Michael Hilary Burke	A process for the preparation of an orally administered unit dose tablet
HU230877B1 (hu)	2008-09-30	2018-11-29	EGIS Gyógyszergyár NyR	Stabil kombinációs gyógyszerkészítmény

2008
- 2008-09-30 HU HUP0800591A patent/HU230877B1/hu unknown
2009
- 2009-09-30 MX MX2011003407A patent/MX2011003407A/es not_active Application Discontinuation
- 2009-09-30 HU HUE09748467A patent/HUE045326T2/hu unknown
- 2009-09-30 RS RSP20190990 patent/RS59201B1/sr unknown
- 2009-09-30 SK SK7-2017U patent/SK7997Y1/sk unknown
- 2009-09-30 ME MEP-2020-76A patent/ME03774B/me unknown
- 2009-09-30 HR HRP20191373 patent/HRP20191373T1/hr unknown
- 2009-09-30 EA EA201100430A patent/EA026238B9/ru not_active IP Right Cessation
- 2009-09-30 RO ROA201100274A patent/RO127490B1/ro unknown
- 2009-09-30 LT LTEP09748467.9T patent/LT2344141T/lt unknown
- 2009-09-30 CZ CZ2011-252A patent/CZ308237B6/cs unknown
- 2009-09-30 DK DK09748467.9T patent/DK2344141T3/da active
- 2009-09-30 EP EP09748467.9A patent/EP2344141B1/en not_active Revoked
- 2009-09-30 UA UAA201105446A patent/UA101407C2/ru unknown
- 2009-09-30 DE DE202009019152.4U patent/DE202009019152U1/de not_active Expired - Lifetime
- 2009-09-30 AT ATA9359/2009A patent/AT510866A3/de active IP Right Grant
- 2009-09-30 MX MX2015016608A patent/MX382264B/es unknown
- 2009-09-30 EP EP11003486.5A patent/EP2359815B1/en not_active Revoked
- 2009-09-30 GE GEAP200912210A patent/GEP20135859B/en unknown
- 2009-09-30 HU HUE11003486A patent/HUE049948T2/hu unknown
- 2009-09-30 SM SM20190434T patent/SMT201900434T1/it unknown
- 2009-09-30 PL PL09748467T patent/PL2344141T3/pl unknown
- 2009-09-30 PL PL11003486T patent/PL2359815T3/pl unknown
- 2009-09-30 WO PCT/HU2009/000085 patent/WO2010038091A2/en not_active Ceased
- 2009-09-30 KR KR1020117009405A patent/KR101772619B1/ko active Active
- 2009-09-30 CN CN200980138060.7A patent/CN102164585B/zh active Active
- 2009-09-30 AT ATGM8014/2015U patent/AT14769U1/de not_active IP Right Cessation
- 2009-09-30 HR HRP20110162AA patent/HRP20110162B1/hr active IP Right Grant
- 2009-09-30 SI SI200931990T patent/SI2344141T1/sl unknown
- 2009-09-30 RU RU2014139476A patent/RU2687282C2/ru active
- 2009-09-30 ES ES201190015A patent/ES2385988B2/es active Active
- 2009-09-30 PT PT09748467T patent/PT2344141T/pt unknown
- 2009-09-30 MY MYPI2011001388A patent/MY175270A/en unknown
- 2009-09-30 PL PL394605A patent/PL394605A1/pl unknown
- 2009-09-30 PT PT2009000085A patent/PT2010038091Y/pt active IP Right Grant
- 2009-09-30 EA EA201691869A patent/EA038392B1/ru unknown
- 2009-09-30 EE EEP201100029A patent/EE05723B1/et unknown
- 2009-09-30 RU RU2011112047/15A patent/RU2549437C2/ru active
- 2009-09-30 SG SG2013073382A patent/SG194392A1/en unknown
- 2009-09-30 RS RS20200397A patent/RS60784B1/sr unknown
- 2009-09-30 SK SK5023-2011A patent/SK288593B6/sk unknown
- 2009-09-30 SI SI200932053T patent/SI2359815T1/sl unknown
- 2009-09-30 ES ES09748467T patent/ES2739900T3/es active Active
- 2009-09-30 RS RS20110136A patent/RS60686B1/sr unknown
- 2009-09-30 PT PT110034865T patent/PT2359815T/pt unknown
- 2009-09-30 LT LTEP11003486.5T patent/LT2359815T/lt unknown
- 2009-09-30 CZ CZ2017-33281U patent/CZ30825U1/cs not_active IP Right Cessation
- 2009-09-30 CH CH00567/11A patent/CH702345B1/de unknown
2011
- 2011-02-24 LT LT2011012A patent/LT5815B/lt unknown
- 2011-04-29 BG BG10110927A patent/BG66274B1/bg unknown
2019
- 2019-07-30 CY CY20191100810T patent/CY1122084T1/el unknown
2020
- 2020-04-08 HR HRP20200614TT patent/HRP20200614T1/hr unknown

Also Published As

Publication number	Publication date
PT2359815T (pt)	2020-04-16
RU2549437C2 (ru)	2015-04-27
AT510866A3 (de)	2014-06-15
HK1155976A1 (zh)	2012-06-01
GEP20135859B (en)	2013-06-25
PL394605A1 (pl)	2011-09-26
PL2344141T3 (pl)	2019-10-31
RU2011112047A (ru)	2012-11-10
EP2359815A1 (en)	2011-08-24
ES2385988A1 (es)	2012-08-06
AT14769U1 (de)	2016-05-15
LT5815B (lt)	2012-02-27
HU230877B1 (hu)	2018-11-29
PL2359815T3 (pl)	2020-11-30
BG110927A (bg)	2011-09-30
EA201100430A1 (ru)	2011-10-31
MY175270A (en)	2020-06-17
SI2344141T1 (sl)	2019-09-30
CZ308237B6 (cs)	2020-03-18
AT510866A2 (de)	2012-07-15
CN102164585B (zh)	2016-04-27
UA101407C2 (ru)	2013-03-25
RS60784B1 (sr)	2020-10-30
DK2344141T3 (da)	2019-08-05
HRP20110162A2 (hr)	2011-06-30
HUE049948T2 (hu)	2020-11-30
SI2359815T1 (sl)	2020-10-30
ES2739900T3 (es)	2020-02-04
LT2344141T (lt)	2019-08-26
EA201691869A1 (ru)	2017-04-28
ME03774B (me)	2021-04-20
RU2687282C2 (ru)	2019-05-13
CY1122084T1 (el)	2020-11-25
RU2014139476A (ru)	2015-06-20
SK288593B6 (sk)	2018-09-03
WO2010038091A2 (en)	2010-04-08
RS60686B1 (sr)	2020-09-30
MX2011003407A (es)	2011-06-20
SMT201900434T1 (it)	2019-09-09
EP2359815B1 (en)	2020-01-08
HRP20191373T1 (hr)	2019-11-01
RO127490B1 (ro)	2022-01-28
HUE045326T2 (hu)	2019-12-30
HRP20110162A8 (hr)	2019-03-22
LT2359815T (lt)	2020-04-27
CZ2011252A3 (cs)	2011-07-07
RO127490A2 (ro)	2012-06-29
WO2010038091A3 (en)	2010-09-23
HRP20110162B1 (hr)	2019-09-20
EE05723B1 (et)	2014-10-15
WO2010038091A9 (en)	2011-04-07
SK72017U1 (sk)	2017-08-02
RS59201B1 (sr)	2019-10-31
HUP0800591A2 (en)	2010-10-28
SK50232011A3 (sk)	2011-08-04
PT2344141T (pt)	2019-08-06
PT2010038091Y (pt)	2020-02-10
DE202009019152U1 (de)	2017-03-06
EA038392B1 (ru)	2021-08-20
LT2011012A (lt)	2011-10-25
RS20110136A1 (sr)	2012-08-31
CZ30825U1 (cs)	2017-07-11
EP2344141B1 (en)	2019-05-01
SK7997Y1 (sk)	2018-02-05
KR101772619B1 (ko)	2017-08-29
CH702345B1 (de)	2014-05-15
CN102164585A (zh)	2011-08-24
EA026238B1 (ru)	2017-03-31
EA026238B9 (ru)	2017-05-31
MX382264B (es)	2025-03-11
ES2385988B2 (es)	2013-12-11
EP2344141A2 (en)	2011-07-20
HU0800591D0 (en)	2008-11-28
KR20110063563A (ko)	2011-06-10
HRP20200614T1 (hr)	2020-10-02
BG66274B1 (bg)	2012-12-28
SG194392A1 (en)	2013-11-29

Publication	Publication Date	Title
BRPI0905717A2 (pt)	2015-07-14	Composição farmacêutica, processo para preparar uma composição farmacêutica e forma de dosagem farmacêutica
BRPI0906962A2 (pt)	2015-07-14	Composto, e, composição farmacêutica
BRPI0906556A2 (pt)	2015-07-07	Composto, e, composição farmacêutica
IL208203A (en)	2016-06-30	Annotations of 3,2-Dihydro-Pyrido-4,1-Exazine and 3,2-Dihydro-4-Oxa-9,1-Diazapananthrene, Preparation Processes and Pharmaceutical Preparations
FI20080492A0 (fi)	2008-09-01	Parannettu syötävä koostumus ja menetelmä sen valmistamiseksi
BRPI1016132A2 (pt)	2016-04-19	composição, formulação farmacêutica, método para fabricar uma formulação farmacêutica estável.
BRPI0917681A2 (pt)	2015-08-04	Composto, e, composição farmacêutica
DK2285357T3 (da)	2014-06-02	Farmaceutisk sammensætning omfattende brivaracetam
BRPI0918360A2 (pt)	2017-10-10	composto, composição farmacêutica e usos de um composto
IL213452A0 (en)	2011-07-31	Phenylpyrimidone compounds, pharmaceutical compositions, preparation methods and uses thereof
BRPI0917579A2 (pt)	2016-10-11	composto, composição farmacêutica, métodos, e, uso de um composto
DK2442799T3 (da)	2017-01-02	Fast farmaceutisk sammensætning omfattende rivaroxaban
FI20070569A0 (fi)	2007-07-25	Uusi stabiili tuote ja menetelmä sen valmistamiseksi
BRPI1007161A2 (pt)	2016-02-23	composição farmacêutica oral, e processo para preparar uma composição
PL2379086T3 (pl)	2016-01-29	Preparat farmeceutyczny
DK2285413T3 (da)	2012-08-27	Farmaceutisk sammensætning
MY144726A (en)	2011-10-31	Diosmetin compounds, process for their preparation and pharmaceutical compositions containing them
BRPI0918487A2 (pt)	2015-12-01	processo para a preparação de uma composição de copolímero, composição, e, uso de uma composição de copolímero
ZA201108292B (en)	2012-07-25	New compounds,pharmaceutical composition and methods relating thereto
BRPI0921313A2 (pt)	2015-12-29	composição farmaucêutica
LT2344141T (lt)	2019-08-26	Kompozicijos, apimančios amlodipiną ir bisoprololį
BRPI0912118A2 (pt)	2015-11-03	composto, composição farmacêutica, e, intermediário sintético
PT2504331E (pt)	2015-02-20	Composto, novas formas desse composto, composições farmacêuticas desse composto e métodos de preparação e utilização
BRPI0914182A2 (pt)	2019-09-24	composto, e, composição farmacêutica
BRPI0912171A2 (pt)	2017-10-31	composição farmacêutica